Rani Therapeutics Holdings Inc (RANI NASDAQ) stock market data APIs
$0.4612
0.02(4.3%)
as of October 10, 2025
Try our APIs with
free plan!
Rani Therapeutics Holdings Inc Financial Data Overview
Price chart is built with
Anychart
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.
Prev. Close
0.4612
Open
0.4796
High
0.4775
Low
0.4582
52 wk Range
0.387-3.75
Market Cap
33 445 K
Shares Outstanding
47 898 K
Revenue
1 200 K
EPS
-0.18
Beta
-0.015
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Rani Therapeutics Holdings Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Rani Therapeutics Holdings Inc data using free add-ons & libraries
Get Rani Therapeutics Holdings Inc Fundamental Data
Rani Therapeutics Holdings Inc Fundamental data includes:
- Net Revenue: 1 200 K
- EBITDA: -44 545 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: -0.29
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Rani Therapeutics Holdings Inc News
New
Keurig Dr Pepper Named Top Dividend Stock With Insider Buying and 3.41% Yield (KDP)
In this series, we look through the most recent Dividend Channel''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. ...
RANI: Second Quarter Financial Results
By John Vandermosten, CFA NASDAQ:RANI READ THE FULL RANI RESEARCH REPORT On August 7th, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) reported second quarter 2025 results. Since our last update, R...
Rani Therapeutics files $200M mixed securities shelf
* Rani Therapeutics (NASDAQ:RANI [https://seekingalpha.com/symbol/RANI]) filed $200M mixed securities shelf. * Filing [https://seekingalpha.com/filing/10285407] MORE ON RANI THERAPEUTICS * Ran...
Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update
Rani Therapeutics, LLC – Announced strategic research collaboration with Chugai for two undisclosed molecules – – Presented preclinical data demonstrating bioequivalence of novel, bispecific G...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
